Literature DB >> 23787694

Receptor binding by an H7N9 influenza virus from humans.

Xiaoli Xiong1, Stephen R Martin, Lesley F Haire, Stephen A Wharton, Rodney S Daniels, Michael S Bennett, John W McCauley, Patrick J Collins, Philip A Walker, John J Skehel, Steven J Gamblin.   

Abstract

Of the 132 people known to have been infected with H7N9 influenza viruses in China, 37 died, and many were severely ill. Infection seems to have involved contact with infected poultry. We have examined the receptor-binding properties of this H7N9 virus and compared them with those of an avian H7N3 virus. We find that the human H7 virus has significantly higher affinity for α-2,6-linked sialic acid analogues ('human receptor') than avian H7 while retaining the strong binding to α-2,3-linked sialic acid analogues ('avian receptor') characteristic of avian viruses. The human H7 virus does not, therefore, have the preference for human versus avian receptors characteristic of pandemic viruses. X-ray crystallography of the receptor-binding protein, haemagglutinin (HA), in complex with receptor analogues indicates that both human and avian receptors adopt different conformations when bound to human H7 HA than they do when bound to avian H7 HA. Human receptor bound to human H7 HA exits the binding site in a different direction to that seen in complexes formed by HAs from pandemic viruses and from an aerosol-transmissible H5 mutant. The human-receptor-binding properties of human H7 probably arise from the introduction of two bulky hydrophobic residues by the substitutions Gln226Leu and Gly186Val. The former is shared with the 1957 H2 and 1968 H3 pandemic viruses and with the aerosol-transmissible H5 mutant. We conclude that the human H7 virus has acquired some of the receptor-binding characteristics that are typical of pandemic viruses, but its retained preference for avian receptor may restrict its further evolution towards a virus that could transmit efficiently between humans, perhaps by binding to avian-receptor-rich mucins in the human respiratory tract rather than to cellular receptors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23787694     DOI: 10.1038/nature12372

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  28 in total

Review 1.  Understanding influenza virus pathogenicity.

Authors:  W Garten; H D Klenk
Journal:  Trends Microbiol       Date:  1999-03       Impact factor: 17.079

2.  Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography.

Authors:  M B Eisen; S Sabesan; J J Skehel; D C Wiley
Journal:  Virology       Date:  1997-05-26       Impact factor: 3.616

3.  Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes.

Authors:  R W Ruigrok; S R Martin; S A Wharton; J J Skehel; P M Bayley; D C Wiley
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

4.  The polypeptide composition of influenza A viruses.

Authors:  J J Skehel; G C Schild
Journal:  Virology       Date:  1971-05       Impact factor: 3.616

Review 5.  Role of hemagglutinin cleavage for the pathogenicity of influenza virus.

Authors:  D A Steinhauer
Journal:  Virology       Date:  1999-05-25       Impact factor: 3.616

6.  Human infection with influenza H9N2.

Authors:  M Peiris; K Y Yuen; C W Leung; K H Chan; P L Ip; R W Lai; W K Orr; K F Shortridge
Journal:  Lancet       Date:  1999-09-11       Impact factor: 79.321

7.  Receptor binding by a ferret-transmissible H5 avian influenza virus.

Authors:  Xiaoli Xiong; Peter J Coombs; Stephen R Martin; Junfeng Liu; Haixia Xiao; John W McCauley; Kathrin Locher; Philip A Walker; Patrick J Collins; Yoshihiro Kawaoka; John J Skehel; Steven J Gamblin
Journal:  Nature       Date:  2013-04-24       Impact factor: 49.962

8.  Avian and human receptor binding by hemagglutinins of influenza A viruses.

Authors:  R J Russell; D J Stevens; L F Haire; S J Gamblin; J J Skehel
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

9.  Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin.

Authors:  Yi Pu Lin; Xiaoli Xiong; Stephen A Wharton; Stephen R Martin; Peter J Coombs; Sebastien G Vachieri; Evangelos Christodoulou; Philip A Walker; Junfeng Liu; John J Skehel; Steven J Gamblin; Alan J Hay; Rodney S Daniels; John W McCauley
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-10       Impact factor: 11.205

10.  Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome.

Authors:  Yu Chen; Weifeng Liang; Shigui Yang; Nanping Wu; Hainv Gao; Jifang Sheng; Hangping Yao; Jianer Wo; Qiang Fang; Dawei Cui; Yongcheng Li; Xing Yao; Yuntao Zhang; Haibo Wu; Shufa Zheng; Hongyan Diao; Shichang Xia; Yanjun Zhang; Kwok-Hung Chan; Hoi-Wah Tsoi; Jade Lee-Lee Teng; Wenjun Song; Pui Wang; Siu-Ying Lau; Min Zheng; Jasper Fuk-Woo Chan; Kelvin Kai-Wang To; Honglin Chen; Lanjuan Li; Kwok-Yung Yuen
Journal:  Lancet       Date:  2013-04-25       Impact factor: 79.321

View more
  150 in total

1.  Structural analysis of the hemagglutinin from the recent 2013 H7N9 influenza virus.

Authors:  Hua Yang; Paul J Carney; Jessie C Chang; Julie M Villanueva; James Stevens
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

2.  The 150-Loop Restricts the Host Specificity of Human H10N8 Influenza Virus.

Authors:  Netanel Tzarum; Robert P de Vries; Wenjie Peng; Andrew J Thompson; Kim M Bouwman; Ryan McBride; Wenli Yu; Xueyong Zhu; Monique H Verheije; James C Paulson; Ian A Wilson
Journal:  Cell Rep       Date:  2017-04-11       Impact factor: 9.423

3.  Unique Structural Features of Influenza Virus H15 Hemagglutinin.

Authors:  Netanel Tzarum; Ryan McBride; Corwin M Nycholat; Wenjie Peng; James C Paulson; Ian A Wilson
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

4.  Influenza: Pathways to human adaptation.

Authors:  David A Steinhauer
Journal:  Nature       Date:  2013-07-17       Impact factor: 49.962

5.  Structural Insight into a Human Neutralizing Antibody against Influenza Virus H7N9.

Authors:  Cong Chen; Liguo Liu; Yan Xiao; Sheng Cui; Jianmin Wang; Qi Jin
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

6.  TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice.

Authors:  Carolin Tarnow; Géraldine Engels; Annika Arendt; Folker Schwalm; Hanna Sediri; Annette Preuss; Peter S Nelson; Wolfgang Garten; Hans-Dieter Klenk; Gülsah Gabriel; Eva Böttcher-Friebertshäuser
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

7.  Identification of amino acid changes that may have been critical for the genesis of A(H7N9) influenza viruses.

Authors:  Gabriele Neumann; Catherine A Macken; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

8.  Structure and receptor binding of the hemagglutinin from a human H6N1 influenza virus.

Authors:  Netanel Tzarum; Robert P de Vries; Xueyong Zhu; Wenli Yu; Ryan McBride; James C Paulson; Ian A Wilson
Journal:  Cell Host Microbe       Date:  2015-03-11       Impact factor: 21.023

9.  H7N9 influenza virus neutralizing antibodies that possess few somatic mutations.

Authors:  Natalie J Thornburg; Heng Zhang; Sandhya Bangaru; Gopal Sapparapu; Nurgun Kose; Rebecca M Lampley; Robin G Bombardi; Yingchun Yu; Stephen Graham; Andre Branchizio; Sandra M Yoder; Michael T Rock; C Buddy Creech; Kathryn M Edwards; David Lee; Sheng Li; Ian A Wilson; Adolfo García-Sastre; Randy A Albrecht; James E Crowe
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

10.  Analysis of recombinant H7N9 wild-type and mutant viruses in pigs shows that the Q226L mutation in HA is important for transmission.

Authors:  Qinfang Liu; Bin Zhou; Wenjun Ma; Bhupinder Bawa; Jingjiao Ma; Wei Wang; Yuekun Lang; Young Lyoo; Rebecca A Halpin; Xudong Lin; Timothy B Stockwell; Richard Webby; David E Wentworth; Juergen A Richt
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.